{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:55:17Z","timestamp":1790686517982,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.anaerobe.2014.06.003","type":"journal-article","created":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T12:18:08Z","timestamp":1402575488000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Production of recombinant botulism antigens: A review of expression systems"],"prefix":"10.1016","volume":"28","author":[{"given":"G.M.S.G.","family":"Moreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.P.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.R.","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.C.F.","family":"Lobato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2014.06.003_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.anaerobe.2013.06.011","article-title":"Efficacy of Clostridium botulinum types C and D toxoid vaccination in Danish cows","volume":"23","author":"Kr\u00fcger","year":"2013","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib2","doi-asserted-by":"crossref","first-page":"e43845","DOI":"10.1371\/journal.pone.0043845","article-title":"Potent neutralization of botulinum neurotoxin\/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jit450","article-title":"Molecular characterization of a novel botulinum neurotoxin type H gene","volume":"209","author":"Dover","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib4","series-title":"Botulism: the organism, its toxins, the disease","author":"Smith","year":"1977"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib5","first-page":"375","article-title":"Clostridiurn argentinense sp. nov.\u202f: a genetically homogeneous group composed of all strains of Clostridium botulinum toxin type G and some nontoxigenic strains previously identified as clostridium subterminale or clostridium hastiforme","volume":"38","author":"Suen","year":"1988","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/jcm.23.1.201-202.1986","article-title":"Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism","volume":"23","author":"McCroskey","year":"1986","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib7","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1128\/jcm.32.8.1911-1917.1994","article-title":"Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms","volume":"32","author":"Franciosa","year":"1994","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib9","doi-asserted-by":"crossref","first-page":"e1003690","DOI":"10.1371\/journal.ppat.1003690","article-title":"Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity","volume":"9","author":"Lee","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870030409","article-title":"Systemic toxicity of botulinum toxin by intramuscular injection in the monkey","volume":"3","author":"Scott","year":"1988","journal-title":"Mov Disord"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.toxicon.2013.06.001","article-title":"Regulation of toxin synthesis in Clostridium botulinum and Clostridium tetani","volume":"75","author":"Connan","year":"2013","journal-title":"Toxicon"},{"issue":"Suppl","key":"10.1016\/j.anaerobe.2014.06.003_bib12","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0151-9638(09)74531-4","article-title":"Mechanisms of action of botulinum toxins and neurotoxins","volume":"136","author":"Poulain","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.mib.2005.08.006","article-title":"Genomics of clostridial pathogens: implication of extrachromosomal elements in pathogenicity","volume":"8","author":"Br\u00fcggemann","year":"2005","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.coph.2009.03.004","article-title":"Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics","volume":"9","author":"Dolly","year":"2009","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.embor.7400796","article-title":"Entering neurons: botulinum toxins and synaptic vesicle recycling","volume":"7","author":"Verderio","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib16","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/IAI.01893-06","article-title":"Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route","volume":"75","author":"Ravichandran","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1615\/CritRevImmunol.v30.i2.50","article-title":"Mode of action of botulinum neurotoxins: current vaccination strategies and molecular immune recognition","volume":"30","author":"Aoki","year":"2010","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0749-0739(17)30053-6","article-title":"Botulism in the horse","volume":"17","author":"Galey","year":"2001","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/vr.153.9.270","article-title":"Outbreak of botulism type B in a dairy cattle herd: clinical and epidemiological aspects","volume":"153","author":"Yeruham","year":"2003","journal-title":"Vet Rec"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/vr.165.18.544-a","article-title":"Detection of Clostridium botulinum type A toxin in a cow in Northern Ireland","volume":"165","author":"Hartley","year":"2009","journal-title":"Vet Rec"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib21","first-page":"77","article-title":"Two outbreaks of type C and type D botulism in sheep and goats in south Africa","volume":"66","author":"Van der Lugt","year":"1995","journal-title":"J\u00a0S Afr Vet Assoc"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/vr.158.22.768","article-title":"Toxicological, bacteriological and serological diagnosis of botulism in a dog","volume":"158","author":"Bruchim","year":"2006","journal-title":"Vet Rec"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/03079457.2010.526923","article-title":"Molecular characterization and comparison of Clostridium botulinum type C avian strains","volume":"39","author":"Skarin","year":"2010","journal-title":"Avian Pathol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.anaerobe.2011.12.011","article-title":"Chronic Clostridium botulinum infections in farmers","volume":"18","author":"Rodloff","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib25","first-page":"29","article-title":"Clostridioses dos animais de produ\u00e7\u00e3o","volume":"20","author":"Lobato","year":"2013","journal-title":"Veterin\u00e1ria e Zootec"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib26","first-page":"188","article-title":"Epizootic botulism of cattle in Brazil","volume":"99","author":"D\u00f6bereiner","year":"1992","journal-title":"Dtsch Tierarztl Wochenschr"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1590\/S0100-736X2001000200002","article-title":"Surtos de botulismo em bovinos no Brasil associados \u00e0 ingest\u00e3o de \u00e1gua contaminada","volume":"21","author":"Dutra","year":"2001","journal-title":"Pesqui Veterin\u00e1ria Bras"},{"issue":"Suppl 1","key":"10.1016\/j.anaerobe.2014.06.003_bib28","first-page":"S191","article-title":"Management of animal botulism outbreaks: from clinical suspicion to practical countermeasures to prevent or minimize outbreaks","volume":"11","author":"Anniballi","year":"2013","journal-title":"Biosecur Bioterror"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1590\/S0034-89101991000500008","article-title":"Bovine botulism: laboratory confirmation of clinical diagnosis in 1986-1989","volume":"25","author":"Baldassi","year":"1991","journal-title":"Rev Sa\u00fade P\u00fablica"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib30","first-page":"23","article-title":"Clostridioses dos pequenos ruminantes","volume":"102","author":"Lobato","year":"2007","journal-title":"Rev Port Ci\u00eancias Veterin\u00e1rias"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1017\/S0950268808000939","article-title":"Type C bovine botulism outbreak due to carcass contaminated non-acidified silage","volume":"137","author":"Myllykoski","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/104063870001200511","article-title":"Fatal Clostridium botulinum toxicosis in eleven Holstein cattle fed round bale barley haylage","volume":"12","author":"Kelch","year":"2000","journal-title":"J\u00a0Vet Diagn Invest"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib33","first-page":"445","article-title":"Botulismo causado pelo Clostridium botulinum tipo B","volume":"40","author":"Lobato","year":"1988","journal-title":"Arq Bras Med Veterin\u00e1ria e Zootec"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib34","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1128\/CVI.00046-06","article-title":"Quantitative analysis of levels of serum immunoglobulin G against botulinum neurotoxin type D and association with protection in natural outbreaks of cattle botulism","volume":"13","author":"Steinman","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jbiotec.2005.03.013","article-title":"A\u00a0new scaleable method for the purification of botulinum neurotoxin type E","volume":"119","author":"Gessler","year":"2005","journal-title":"J\u00a0Biotechnol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/erv.13.37","article-title":"What next for botulism vaccine development?","volume":"12","author":"Webb","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2131\/jts.35.9","article-title":"Production and characterization of a recombinant chimeric antigen consisting botulinum neurotoxin serotypes A, B and E binding subdomains","volume":"35","author":"Ebrahimi","year":"2010","journal-title":"J\u00a0Toxicol Sci"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib38","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/iai.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib39","first-page":"496","article-title":"Vaccination with recombinant whole heavy chain fragments of clostridium botulinum type C and D neurotoxins","volume":"11","author":"Arimitsu","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib40","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1016\/j.vaccine.2009.07.021","article-title":"Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D","volume":"27","author":"Stahl","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2013.11.025","article-title":"Vaccination of cattle with a recombinant bivalent toxoid against botulism serotypes C and D","volume":"32","author":"Cunha","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.toxicon.2006.02.013","article-title":"Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (HC)) immune response and protection in the rhesus monkey","volume":"47","author":"Boles","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10295-011-1082-9","article-title":"Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements","volume":"39","author":"Huang","year":"2012","journal-title":"J\u00a0Ind Microbiol Biotechnol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib44","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","article-title":"Development of recombinant vaccines for botulinum neurotoxin","volume":"36","author":"Smith","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib45","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1016\/j.vaccine.2009.08.059","article-title":"Botulism and vaccines for its prevention","volume":"27","author":"Smith","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/biot.200500051","article-title":"Manufacturing of recombinant therapeutic proteins in microbial systems","volume":"1","author":"Graumann","year":"2006","journal-title":"Biotechnol J"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4161\/hv.6.6.11709","article-title":"Expression of Hc fragment from Clostridium botulinum neurotoxin serotype B in Escherichia coli and its use as a good immunogen","volume":"6","author":"Gao","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib48","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4014\/jmb.1010.10047","article-title":"Effect of adjuvants on antibody titer of synthetic recombinant light chain of botulinum neurotoxin type B and its diagnostic potential for botulism","volume":"21","author":"Jain","year":"2011","journal-title":"J\u00a0Microbiol Biotechnol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib49","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/iai.65.11.4586-4591.1997","article-title":"Induction of an immune response by oral administration of recombinant botulinum toxin","volume":"65","author":"Kiyatkin","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib50","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.copbio.2006.06.003","article-title":"Enhancement of soluble protein expression through the use of fusion tags","volume":"17","author":"Esposito","year":"2006","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib51","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1348-0421.2007.tb03919.x","article-title":"C\u00a0terminal half fragment (50 kDa) of heavy chain components of Clostridium botulinum type C and D neurotoxins can be used as an effective vaccine","volume":"51","author":"Lee","year":"2007","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib52","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/CVI.00239-08","article-title":"Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine","volume":"15","author":"Yu","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib53","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","article-title":"The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.clim.2010.07.005","article-title":"Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F","volume":"137","author":"Yu","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib55","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0264-410X(00)00155-9","article-title":"Cloning, expression and evaluation of a recombinant sub-unit vaccine against Clostridium botulinum type F toxin","volume":"15","author":"Holley","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00449-011-0579-y","article-title":"High level expression of recombinant BoNT\/A-Hc by high cell density cultivation of Escherichia coli","volume":"35","author":"Yari","year":"2012","journal-title":"Bioprocess Biosyst Eng"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1042\/BA20090315","article-title":"Optimization of the BoNT\/A-Hc expression in recombinant Escherichia coli using the Taguchi statistical method","volume":"56","author":"Yari","year":"2010","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib58","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/IAI.71.5.2941-2944.2003","article-title":"Expression of H C subunits from Clostridium botulinum types C and D and their evaluation as candidate vaccine antigens in mice","volume":"71","author":"Woodward","year":"2003","journal-title":"Infection Immnunity"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib59","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib60","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib61","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/b93995","article-title":"Inclusion bodies: formation and utilisation","volume":"89","author":"Fahnert","year":"2004","journal-title":"Physiol Stress Responses"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib62","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0041-0101(03)00042-4","article-title":"Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants","volume":"41","author":"Jensen","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib63","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2746\/042516407X236550","article-title":"Alternative vaccination against equine botulism (BoNT\/C)","volume":"39","author":"Frey","year":"2007","journal-title":"Equine Vet J"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pep.2005.07.020","article-title":"Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A","volume":"45","author":"Sharma","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib65","doi-asserted-by":"crossref","first-page":"35164","DOI":"10.1074\/jbc.M507596200","article-title":"Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins","volume":"280","author":"Tsukamoto","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pep.2009.11.007","article-title":"Improved soluble expression and characterization of the Hc domain of Clostridium botulinum neurotoxin serotype A in Escherichia coli by using a PCR-synthesized gene and a Trx co-expression strain","volume":"71","author":"Chen","year":"2010","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biologicals.2009.09.008","article-title":"Cloning, high level expression and immunogenicity of 1163-1256 residues of C-terminal heavy chain of C. botulinum neurotoxin type E","volume":"38","author":"Mansour","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pep.2003.10.015","article-title":"Cloning, high-level expression, single-step purification, and binding activity of His6-tagged recombinant type B botulinum neurotoxin heavy chain transmembrane and binding domain","volume":"34","author":"Zhou","year":"2004","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib69","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pep.2005.09.024","article-title":"Expression, purification, and characterization of Clostridium botulinum type B light chain","volume":"46","author":"Gilsdorf","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib70","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/IAI.01252-08","article-title":"Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes","volume":"77","author":"Shone","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib71","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1128\/IAI.00382-13","article-title":"Enhancing the protective immune response against botulism","volume":"81","author":"Przedpelski","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib72","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/nar\/19.7.1461","article-title":"Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA","volume":"19","author":"Romanos","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib73","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/prep.2000.1200","article-title":"Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris","volume":"18","author":"Byrne","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pep.2010.09.016","article-title":"Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H(c))] expressed in Pichia pastoris","volume":"75","author":"Dux","year":"2011","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2003.07.003","article-title":"Scale-up of the fermentation and purification of the recombinant heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastoris","volume":"32","author":"Johnson","year":"2003","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib76","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.4049\/jimmunol.177.8.5524","article-title":"Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A","volume":"177","author":"Maddaloni","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib77","doi-asserted-by":"crossref","first-page":"e16532","DOI":"10.1371\/journal.pone.0016532","article-title":"Mucosal targeting of a BoNT\/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT\/A neutralizing antibodies in rabbits","volume":"6","author":"Staats","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib78","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib79","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2009.05.030","article-title":"Production of catalytically inactive BoNT\/A1 holoprotein and comparison with BoNT\/A1 subunit vaccines against toxin subtypes A1, A2, and A3","volume":"27","author":"Webb","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib80","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2141.2003.04754.x","article-title":"Beta+45 G C: a novel silent beta-thalassaemia mutation, the first in the Kozak sequence","volume":"124","author":"De Angioletti","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib81","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib82","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/prep.1998.0910","article-title":"Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris","volume":"13","author":"Potter","year":"1998","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib83","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/bit.260220605","article-title":"Immobilized yeast cells with methanol oxidase activity: preparation and enzymatic properties","volume":"22","author":"Couderc","year":"1980","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib84","doi-asserted-by":"crossref","first-page":"e69692","DOI":"10.1371\/journal.pone.0069692","article-title":"Production and evaluation of a recombinant chimeric vaccine against Clostridium botulinum neurotoxin types C and D","volume":"8","author":"Gil","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib85","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jbiotec.2006.07.022","article-title":"Cell bank characterization and fermentation optimization for production of recombinant heavy chain C-terminal fragment of botulinum neurotoxin serotype E (rBoNTE(H(c)): antigen E) by Pichia pastoris","volume":"127","author":"Sinha","year":"2007","journal-title":"J\u00a0Biotechnol"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-4-33","article-title":"Recombinant production of bacterial toxins and their derivatives in the methylotrophic yeast Pichia pastoris","volume":"4","author":"Gurkan","year":"2005","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-11-22","article-title":"Recombinant protein expression in Pichia pastoris strains with an engineered methanol utilization pathway","volume":"11","author":"Krainer","year":"2012","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib88","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/IAI.69.9.5709-5715.2001","article-title":"Candidate vaccine against botulinum neurotoxin serotype a derived from a venezuelan equine encephalitis virus vector system","volume":"69","author":"Lee","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib89","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1016\/j.vaccine.2009.08.022","article-title":"Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based semliki forest virus vectors","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2014.06.003_bib90","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1128\/CVI.00496-09","article-title":"Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system","volume":"17","author":"Zichel","year":"2010","journal-title":"Clin Vaccine Immunol"}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996414000766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996414000766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:00:29Z","timestamp":1790683229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996414000766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":90,"alternative-id":["S1075996414000766"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2014.06.003","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production of recombinant botulism antigens: A review of expression systems","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2014.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}